Perspective Therapeutics (CATX) FCF Margin (2010 - 2023)
Perspective Therapeutics recorded quarterly FCF Margin of 185.58% in Q4 2023, up 136.61% quarter-over-quarter from 506.86% in Q3 2023.
Perspective Therapeutics' FCF Margin history runs 14 years deep, the most recent figure standing at 185.58% for Q4 2023.
- In Q4 2023, FCF Margin changed N/A year-over-year to 185.58%; the TTM figure through Dec 2023 stood at 6196.57% (changed N/A YoY), while the FY2023 annual figure was 2648.88%, changed N/A from the prior year.
- FCF Margin came in at 185.58% for Q4 2023 at Perspective Therapeutics, up from 506.86% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 185.58% in Q4 2023 to a low of 542.3% in Q1 2023.
- A 5-year average of 116.0% and a median of 52.88% in 2019 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin surged 13302 bps in 2021 and sank 49247 bps in 2023, its largest moves.
- Perspective Therapeutics' FCF Margin stood at 62.74% in 2019, then surged by 45 bps to 34.76% in 2020, then jumped by 383 bps to 98.26% in 2021, then slumped by 210 bps to 107.92% in 2022, then surged by 272 bps to 185.58% in 2023.
- According to Business Quant data, FCF Margin over the past three periods registered 185.58%, 506.86%, and 525.93% for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 185.58% |
| Sep 30, 2023 | -506.86% |
| Jun 30, 2023 | -525.93% |
| Mar 31, 2023 | -542.30% |
| Sep 30, 2022 | -107.92% |
| Jun 30, 2022 | -177.49% |
| Mar 31, 2022 | -49.83% |
| Dec 31, 2021 | 98.26% |
| Sep 30, 2021 | -83.39% |
| Mar 31, 2021 | -27.46% |
| Dec 31, 2020 | -34.76% |
| Sep 30, 2020 | -18.92% |
| Jun 30, 2020 | -38.31% |
| Mar 31, 2020 | -31.46% |
| Dec 31, 2019 | -62.74% |
| Sep 30, 2019 | -32.44% |
| Jun 30, 2019 | -55.93% |
| Mar 31, 2019 | -76.20% |
| Dec 31, 2018 | -64.34% |
| Sep 30, 2018 | -110.50% |
| Jun 30, 2018 | -96.94% |
| Mar 31, 2018 | -73.81% |
| Dec 31, 2017 | -105.40% |
| Sep 30, 2017 | -141.62% |
| Jun 30, 2017 | -107.23% |
| Mar 31, 2017 | -120.05% |
| Dec 31, 2016 | -170.53% |
| Sep 30, 2016 | -138.76% |
| Jun 30, 2016 | -143.66% |
| Mar 31, 2016 | -81.89% |
| Dec 31, 2015 | -70.82% |
| Sep 30, 2015 | -88.26% |
| Jun 30, 2015 | -46.95% |
| Mar 31, 2015 | -100.52% |
| Jun 30, 2014 | -104.44% |
| Mar 31, 2014 | -44.35% |
| Dec 31, 2013 | -79.08% |
| Sep 30, 2013 | -85.16% |
| Jun 30, 2013 | -63.31% |
| Mar 31, 2013 | -60.48% |
| Dec 31, 2012 | -58.88% |
| Sep 30, 2012 | -88.87% |
| Jun 30, 2012 | -49.76% |
| Mar 31, 2012 | -62.10% |
| Dec 31, 2011 | -39.33% |
| Sep 30, 2011 | -45.23% |
| Jun 30, 2011 | -51.16% |
| Mar 31, 2011 | -42.05% |
| Dec 31, 2010 | -54.50% |
| Sep 30, 2010 | -48.39% |